View by Specialty

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

Cell Therapy News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 14, 2024
4 min read
Save

Multi-engineered CAR-T confers significant, rapid reduction of aggressive brain tumor

Multi-engineered CAR-T confers significant, rapid reduction of aggressive brain tumor

A novel chimeric antigen receptor T-cell therapy produced significant tumor reductions in patients with glioblastoma, results from a phase 1 trial published in The New England Journal of Medicine showed.

SPONSORED CONTENT
March 13, 2024
4 min read
Save

Risk factors identified for secondary leukemia in patients who received CAR T cells

Risk factors identified for secondary leukemia in patients who received CAR T cells

Researchers at Mayo Clinic have identified clinical factors associated with increased risk for developing myeloid neoplasms following chimeric antigen receptor T-cell therapy, according to data published in JAMA Oncology.

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

SPONSORED CONTENT
March 11, 2024
1 min read
Save

CAR-T shows ‘superior outcomes’ in adults with post-transplant relapsed leukemia

CAR-T shows ‘superior outcomes’ in adults with post-transplant relapsed leukemia

Patients with post-transplant relapsed B-cell acute lymphoblastic leukemia who received chimeric antigen receptor T-cell therapy had superior outcomes compared with alternative approaches, study results showed.

SPONSORED CONTENT
March 10, 2024
2 min read
Save

BLOG: Caring for patients receiving adoptive cellular therapy

BLOG: Caring for patients receiving adoptive cellular therapy

Adoptive cellular therapies such as chimeric antigen receptor T-cell therapy have transformed the landscape of care for patients with relapsed or refractory hematologic malignancies.

SPONSORED CONTENT
March 08, 2024
3 min read
Save

Health care professionals enthusiastic about approval of first cell therapy for melanoma

An analysis of global online conversations among health care professionals on social media in February showed an overarching sense of enthusiasm about FDA approval of the first cellular therapy to treat unresectable or metastatic melanoma.

SPONSORED CONTENT
March 06, 2024
3 min read
Save

Liquid biopsy offers ‘meaningful approach’ to understanding CAR-T

Liquid biopsy offers ‘meaningful approach’ to understanding CAR-T

Liquid biopsy could provide enhanced information about chimeric antigen receptor T-cell therapy compared with normally used DNA, RNA and protein assays, according to findings published in Journal for ImmunoTherapy of Cancer.

SPONSORED CONTENT
March 05, 2024
2 min read
Save

‘Off-the-shelf’ cell therapy shows ‘very encouraging’ results for B-cell malignancies

‘Off-the-shelf’ cell therapy shows ‘very encouraging’ results for B-cell malignancies

Nearly one-half of adults with relapsed or refractory CD19-positive B-cell malignancies responded to treatment with a novel cord blood-derived natural killer cell therapy expressing a chimeric antigen receptor, study results showed.

SPONSORED CONTENT
March 04, 2024
4 min read
Save

‘Gratifying’ results show ‘incredible step forward’ for off-the-shelf T-cell therapies

‘Gratifying’ results show ‘incredible step forward’ for off-the-shelf T-cell therapies

The first published results of a phase 3 allogeneic T-cell therapy showed a better than 50% response rate in patients with relapsed or refractory Epstein-Barr virus-positive post-transplant lymphoproliferative disease.

SPONSORED CONTENT
March 01, 2024
1 min read
Save

AACR to honor Steven A. Rosenberg, MD, PhD, for lifetime achievement in cancer research

AACR to honor Steven A. Rosenberg, MD, PhD, for lifetime achievement in cancer research

Steven A. Rosenberg, MD, PhD, FAACR, will be awarded the 2024 American Association for Cancer Research Award for Lifetime Achievement in Cancer Research during the AACR Annual Meeting in San Diego.

SPONSORED CONTENT
February 29, 2024
3 min read
Save

Development of T-cell lymphoma 'very serious' but 'very rare' after CAR T-cell therapy

Development of T-cell lymphoma 'very serious' but 'very rare' after CAR T-cell therapy

More evidence has emerged that T-cell lymphoma following chimeric antigen receptor T-cell therapy is both rare and not necessarily caused by the treatment.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails